ArticleFrontiers in immunology2026
Plasma haem oxygenase-1 and interleukin-6 as adjunct host biomarkers associated with malaria.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Naturally acquired malaria is associated with shorter leukocyte relative telomere length and increased hTERT expression in an endemic nigerian population.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Malaria pathogenesis involves both parasite burden and host inflammatory and oxidative stress responses that contribute to haematological alterations. Full blood count (FBC)-derived indices have been explored as accessible surrogate biomarkers, reflecting systemic inflammatory changes; however, they provide limited mechanistic insight into underlying haem-driven oxidative stress pathways. Haem oxygenase-1 (HO-1) reflects cellular responses to free haem, while interleukin-6 (IL-6) mediates systemic inflammation. However, their combined role in relation to parasitaemia and haematological alterations in endemic populations remains insufficiently defined. This study evaluated plasma HO-1 and IL-6 as complementary host-response biomarkers in a hospital-based malaria-endemic population. Methods: This cross-sectional study was conducted at Covenant University Medical Centre (CUMC), Canaanland, Ota, Ogun State, Nigeria. A total of 647 individuals were screened, and 304 participants with complete microscopy and haematological data were retained in the analytical cohort (152 microscopy-positive and 152 microscopy-negative). An integrated biomarker subset of 40 participants with matched plasma samples and complete laboratory data was used for ELISA, correlation, and receiver operating characteristic (ROC) analyses. Group comparisons used Mann-Whitney U and Kruskal-Wallis tests, categorical variables were compared using chi-square or Fisher exact tests, and associations were assessed using Spearman correlation. Results: In the analytical cohort, microscopy-positive participants had lower haemoglobin, haematocrit, red-cell count, mean cell indices, and platelet counts, together with higher temperature and white-cell counts than microscopy-negative participants (all p< 0.001 for the major contrasts). Fever and anaemia were also substantially more frequent in microscopy-positive participants. In the biomarker subset, IL-6 was significantly higher in malaria-positive participants than malaria-negative participants (median 141.28 vs 106.58 pg/mL; p = 0.027), whereas HO-1 showed a non-significant upward shift (230.98 vs 193.73 ng/mL; p = 0.131). IL-6 correlated positively with HO-1 (rho = 0.702, p< 0.001), parasitaemia (rho = 0.387, p = 0.015), and temperature (rho = 0.432, p = 0.006), and negatively with haemoglobin (rho = -0.417, p = 0.008). ROC analysis showed moderate discriminatory performance for IL-6 and lower performance for HO-1. IL-6 yielded an AUC of 0.709 (95% CI 0.531-0.874), with sensitivity of 72.7% and specificity of 76.5% at the Youden-optimal threshold. HO-1 yielded an AUC of 0.641 (95% CI 0.440-0.826), while the combined IL-6 + HO-1 model yielded an AUC of 0.687 (95% CI 0.461-0.886). Conclusions: IL-6 showed better discriminatory performance than HO-1 in this cohort, while HO-1 demonstrated only modest and non-significant differences between groups. These findings suggest that IL-6 may be a more informative adjunct inflammatory marker in malaria, whereas the role of HO-1 requires further validation in larger studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.